炎症性肠病和急性自限性结肠炎中隐窝脓肿相关的微生物组。
Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.
机构信息
Gastroenterology and Nutrition Department, Saint Antoine Hospital, Pierre et Marie Curie-Paris6 University, AP-HP, 184 rue du Faubourg Saint-Antoine, 75571, Paris, France.
出版信息
World J Gastroenterol. 2010 Feb 7;16(5):583-7. doi: 10.3748/wjg.v16.i5.583.
Abstract
AIM
To evaluate whether crypt abscesses from inflammatory bowel disease (IBD) patients contain bacteria and to establish their nature.
METHODS
We studied 17 ulcerative colitis patients, 11 Crohn's disease patients, 7 patients with acute self-limited colitis (ASLC) and normal colonic biopsies from 5 subjects who underwent colonoscopy for colon cancer screening. A fluorescent in situ hybridization technique was applied to colonic biopsies to assess the microbiota composition of the crypts and crypt abscesses.
RESULTS
Crypts colonized by bacteria were observed in 42.9% and 3.6% of ASLC and IBD patients, respectively (P = 0.019). Crypt abscesses colonized by bacteria were observed in 28.6% and 0.0% of ASLC and IBD patients, respectively (P = 0.035).
CONCLUSION
These results do not support the hypothesis that crypt abscesses in IBD are the result of localized dysbiosis arising from persistence of living bacteria colonizing the crypts.
摘要
目的
评估炎症性肠病（IBD）患者的隐窝脓肿中是否存在细菌，并确定其性质。
方法
我们研究了 17 例溃疡性结肠炎患者、11 例克罗恩病患者、7 例急性自限性结肠炎（ASLC）患者和 5 例因结肠癌筛查而行结肠镜检查的正常结肠活检患者的隐窝脓肿。应用荧光原位杂交技术评估结肠隐窝和隐窝脓肿的微生物群落组成。
结果
分别有 42.9%和 3.6%的 ASLC 和 IBD 患者的隐窝被细菌定植（P=0.019）。分别有 28.6%和 0.0%的 ASLC 和 IBD 患者的隐窝脓肿被细菌定植（P=0.035）。
结论
这些结果不支持 IBD 患者的隐窝脓肿是由定植于隐窝的活菌引起的局部菌群失调的假说。
相似文献
1
Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.炎症性肠病和急性自限性结肠炎中隐窝脓肿相关的微生物组。
World J Gastroenterol. 2010 Feb 7;16(5):583-7. doi: 10.3748/wjg.v16.i5.583.
2
Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis.胶原性结肠炎和淋巴细胞性结肠炎中炎症性肠病样形态学特征的患病率及意义
Am J Surg Pathol. 2002 Nov;26(11):1414-23. doi: 10.1097/00000478-200211000-00003.
3
Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.人类的隐窝和黏膜相关核心微生物群及其在结肠癌患者中的改变。
mBio. 2019 Jul 16;10(4):e01315-19. doi: 10.1128/mBio.01315-19.
4
Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease.结肠炎的黏膜活检诊断：急性自限性结肠炎和特发性炎症性肠病。
Gastroenterology. 1994 Sep;107(3):755-63. doi: 10.1016/0016-5085(94)90124-4.
5
The Apoptotic Crypt Abscess: An Underappreciated Histologic Finding in Gastrointestinal Pathology.凋亡性隐窝脓肿：胃肠道病理学中一项未得到充分重视的组织学表现。
Am J Clin Pathol. 2017 Nov 20;148(6):538-544. doi: 10.1093/ajcp/aqx100.
6
Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.炎症性肠病中直肠黏膜相关细菌菌群的分子特征分析
Inflamm Bowel Dis. 2005 May;11(5):481-7. doi: 10.1097/01.mib.0000159663.62651.4f.
7
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.患有炎症性肠病的儿科患者的肠道相关细菌微生物群。
Gut. 2006 Dec;55(12):1760-7. doi: 10.1136/gut.2005.078824. Epub 2006 Apr 28.
8
Crypts in Asymmetric Fission in Endoscopic Biopsies from Swedish Patients With Inflammatory Bowel Disease.内镜活检中来自炎症性肠病瑞典患者的非对称分裂隐窝
Anticancer Res. 2021 Jul;41(7):3511-3517. doi: 10.21873/anticanres.15138.
9
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.青少年炎症性肠病的黏膜细菌菌群和黏液层厚度。
World J Gastroenterol. 2009 Nov 14;15(42):5287-94. doi: 10.3748/wjg.15.5287.
引用本文的文献
1
The practice of fecal microbiota transplantation in inflammatory bowel disease.粪便微生物群移植在炎症性肠病中的应用
Intest Res. 2024 Jan;22(1):44-64. doi: 10.5217/ir.2023.00085. Epub 2023 Nov 21.
2
Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.人类的隐窝和黏膜相关核心微生物群及其在结肠癌患者中的改变。
mBio. 2019 Jul 16;10(4):e01315-19. doi: 10.1128/mBio.01315-19.
3
Comparative pathophysiology and management of protein-losing enteropathy.蛋白质丢失性肠病的比较病理生理学与管理
J Vet Intern Med. 2019 Mar;33(2):383-402. doi: 10.1111/jvim.15406. Epub 2019 Feb 14.
4
Role of gut microbiota in intestinal wound healing and barrier function.肠道微生物群在肠道伤口愈合和屏障功能中的作用。
Tissue Barriers. 2018;6(3):1539595. doi: 10.1080/21688370.2018.1539595. Epub 2018 Nov 7.
5
Micromanagement in the gut: microenvironmental factors govern colon mucosal biofilm structure and functionality.肠道中的微观管理：微环境因素决定结肠黏膜生物膜的结构和功能。
NPJ Biofilms Microbiomes. 2015 Dec 16;1:15026. doi: 10.1038/npjbiofilms.2015.26. eCollection 2015.
6
Temperate phages acquire DNA from defective prophages by relaxed homologous recombination: the role of Rad52-like recombinases.温和噬菌体通过松弛同源重组从缺陷原噬菌体获取DNA：类Rad52重组酶的作用。
PLoS Genet. 2014 Mar 6;10(3):e1004181. doi: 10.1371/journal.pgen.1004181. eCollection 2014 Mar.
7
Heat shock factor 2 levels are associated with the severity of ulcerative colitis.热休克因子2水平与溃疡性结肠炎的严重程度相关。
PLoS One. 2014 Feb 12;9(2):e88822. doi: 10.1371/journal.pone.0088822. eCollection 2014.
8
A crypt-specific core microbiota resides in the mouse colon.肠道中存在特定于隐窝的核心微生物群。
mBio. 2012 May 22;3(3). doi: 10.1128/mBio.00116-12. Print 2012.
9
The potter's wheel: the host's role in sculpting its microbiota.陶轮：塑造其微生物群的主人角色。
Cell Mol Life Sci. 2011 Nov;68(22):3675-85. doi: 10.1007/s00018-011-0830-3. Epub 2011 Oct 4.
10
Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions.生理和病理条件下的肠道宿主-微生物相互作用
Int J Inflam. 2010 Sep 29;2010:386956. doi: 10.4061/2010/386956.
本文引用的文献
1
Analysis of bacterial bowel communities of IBD patients: what has it revealed?炎症性肠病患者肠道细菌群落分析：揭示了什么？
Inflamm Bowel Dis. 2008 Jun;14(6):858-67. doi: 10.1002/ibd.20392.
2
Defensins and other antimicrobial peptides in inflammatory bowel disease.炎症性肠病中的防御素及其他抗菌肽。
Curr Opin Gastroenterol. 2007 Jul;23(4):370-8. doi: 10.1097/MOG.0b013e328136c580.
3
Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.回肠克罗恩病黏膜病变的斑片状分布与主要黏膜相关细菌的差异无关：一项使用荧光原位杂交和时间温度梯度凝胶电泳的研究
Inflamm Bowel Dis. 2007 Jun;13(6):684-92. doi: 10.1002/ibd.20084.
4
Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis.溃疡性结肠炎中与受损黏膜和健康黏膜相关的优势微生物群的分子比较。
Gut. 2007 Jan;56(1):152-4. doi: 10.1136/gut.2006.109686.
5
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.综述文章：细菌在炎症性肠病发病及持续发展中的作用
Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:11-8. doi: 10.1111/j.1365-2036.2006.03053.x.
6
Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis.粪便16S rRNA的温度梯度凝胶电泳显示溃疡性结肠炎患者微生物群中存在活跃的大肠杆菌。
J Clin Microbiol. 2006 Sep;44(9):3172-7. doi: 10.1128/JCM.02600-05.
7
Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule.通过肠胃外给予病原体衍生的免疫调节分子预防实验性结肠炎。
Gut. 2007 Mar;56(3):351-7. doi: 10.1136/gut.2006.099861. Epub 2006 Sep 4.
8
Pathogen-derived immunomodulatory molecules: future immunotherapeutics?病原体衍生的免疫调节分子：未来的免疫疗法？
Trends Immunol. 2006 Oct;27(10):470-6. doi: 10.1016/j.it.2006.08.002. Epub 2006 Aug 21.
9
Specificities of the fecal microbiota in inflammatory bowel disease.炎症性肠病中粪便微生物群的特异性
Inflamm Bowel Dis. 2006 Feb;12(2):106-11. doi: 10.1097/01.MIB.0000200323.38139.c6.
10
Reduced Paneth cell alpha-defensins in ileal Crohn's disease.回肠克罗恩病中潘氏细胞α-防御素减少
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18129-34. doi: 10.1073/pnas.0505256102. Epub 2005 Dec 5.
Zotero 插件